Hedge fund Rubric Capital has said that some private credit managers are using accounting techniques to make balance sheets appear less leveraged, according to a report by Reuters citing a letter from the firm.
Apollo has cut the dividend and marked down the value of the portfolio of one of its private credit funds, citing strain in parts of its loan book as interest rate dynamics shift, according to a report by Bloomberg.
KKR’s publicly traded credit vehicle, FS KKR Capital Corporation, fell 15% after reporting a rise in troubled loans and lower investment income, highlighting stress in private credit markets, according to a report by the Financial Times.
Global private equity firm Carlyle Group has set a target to raise $200bn in new assets by 2028, aiming to bolster fee-related earnings and expand its investment footprint, according to a report by Reuters.
Arcmont Asset Management, a European private credit asset management firm and affiliate of Nuveen, has closed Capital Solutions Fund II and associated vehicles, raising total investable capital of €1.5bn. The fund has nearly doubled in size versus its predecessor.
A publicly listed private credit vehicle managed by Blackstone has flagged continued stress in one of its largest holdings, marking down its exposure to software company Medallia, according to a report by Bloomberg.
Ardian may step back from certain software-related private credit investments as artificial intelligence reshapes business models and credit risk, according to a Bloomberg interview with the firm’s deputy head of private credit, Guillaume Chinardet.
Private credit investment into emerging markets rose to a record $22.3bn last year, almost 40% above the previous peak in 2022, as investors sought alternative sources of yield amid tighter bank lending and increased volatility in developed markets, according to a report by Reuters citing data from the Global Private
Private equity firm General Atlantic is seeking to sell a stake in ByteDance, in a transaction that values the social media group at around $550bn, according to a report by Reuters.
EQT AB has decided not to proceed with a takeover offer for Oxford Biomedica, according to a report by Reuters, after previous plans were rejected on the grounds that they undervalued the business.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
